ClinicalTrials.gg

Neuromuscular Diseases clinical trials

The registry lists 361 studies for Neuromuscular Diseases across more than 10 countries. 97 are recruiting or about to start. 131 of them are mainly about Neuromuscular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 96 narrower conditions too, such as Fibromyalgia: 14,830 studies, 3,487 open.

Get an email when these change. Save the Neuromuscular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
173
Recruiting
70
Status unknown
34
Terminated
28
Not yet recruiting
20
Active, not recruiting
18

Phase

Phase 2
37
Phase 1
25
Phase 3
24
Phase 4
3
Early Phase 1
1

Where

United States
120
France
84
United Kingdom
48
Spain
35
Canada
34
Germany
32

What is being tested here

Drugs under test in Neuromuscular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

33studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 70 Neuromuscular Diseases studies recruiting now, 39 (56%) set no upper age limit and 23 (33%) stop at 75 or younger. 36 (51%) take children under 18. 1 (1%) are for women only and 3 (4%) for men only; 16 (23%) take healthy volunteers.

Recruiting studies that take each age, of 70
AgeWomenMen
1028 (40%)31 (44%)
1858 (83%)59 (84%)
3057 (81%)56 (80%)
4057 (81%)56 (80%)
5056 (80%)55 (79%)
6554 (77%)53 (76%)
7549 (70%)48 (69%)
8546 (66%)45 (64%)

Across all 361 studies, recruiting or not: 41% stop at 75 or younger and 34% at 65; 47% take children; 1% are for women only and 8% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neuromuscular Diseases studies take

Of 84 interventional studies with no phase under Neuromuscular Diseases, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase25 mo12–43 · 84 studies—31 mo18–47 · 75 studies
Observational37 mo12–114 · 70 studies—38 mo12–114 · 64 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 361. Browse all 361 → or search them.